Comparison with Other Growth Hormone Secretagogues Reference: Title: Comparative Effects of Sermorelin and Hexarelin on Growth Hormone Secretion in Aging Authors: Ezio Ghigo, Enzo Arvat, Luca Gianotti, et al
Villanger, G
JACC Basic Transl
He also said the FDA reviews "establish that for all of the seven peptides the evidence for efficacy is either extremely thin or non-existent." Lurie said that there are several risks consumers face when buying peptides currently, including "contaminants, especially infection, due to poor compounding practices, wasteful expenditures of funds of products that are not known to work, and, perhaps most importantly, diversion from actually effective products approved by FDA." He added that he thought there "should be research on these and patients can enroll in trials
That practicality is what makes the injectable format more suitable for programs where the goal is sustained glutathione support over weeks or months rather than a single high-dose session
Regularly evaluate such patients for signs of sedation and respiratory depression, particularly when initiating therapy with acetaminophen and codeine phosphate tablets